Publications by authors named "Natalia Manilo"

Claim this Profile
F
Flare during tapering of biological DMARDs in patients with rheumatoid arthritis in routine care: characteristics and predictors.
L Terslev, Mikkel Ostergaard, Stylianos Georgiadis, Cecilie Heegaard Brahe, Karen Ellegaard, Natalia Manilo

RMD Open· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease: clinical outcomes in real-world patients from the DANBIO registry.
Hafsah Nabi, Oliver Hendricks, Dorte Vendelbo Jensen, Anne Gitte Loft, Jens Kristian Pedersen, Natalia Manilo

RMD Open· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doppler ultrasound predicts successful discontinuation of biological DMARDs in rheumatoid arthritis patients in clinical remission.
Lene Terslev, Cecilie Heegaard Brahe, Merete Lund Hetland, Stylianos Georgiadis, Karen Ellegaard, Natalia Manilo

Rheumatology (Oxford)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of two adalimumab biosimilars in 1318 real-world patients with inflammatory rheumatic disease mandated to switch from originator adalimumab: nationwide observational study emulating a randomised clinical trial.
Hafsah Nabi, Stylianos Georgiadis, Anne Gitte Loft, Oliver Hendricks, Dorte Vendelbo Jensen, Natalia Manilo

Ann Rheum Dis· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): an observational nationwide study applying linkage between DANBIO and national registries.
Bente Glintborg, Stylianos Georgiadis, Anne Gitte Loft, Asta Linauskas, Hanne Lindegaard, Natalia Manilo

Ann Rheum Dis· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to ''To switch or not to switch': the missing piece in the puzzle of biosimilar literature?' by Scherlinger .
Bente Glintborg, Anne Gitte Loft, Emina Omerovic, Oliver Hendricks, Asta Linauskas, Natalia Manilo

Ann Rheum Dis· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between MRI findings and patient-reported outcomes in patients with rheumatoid arthritis in clinical remission and at relapse.
Daniel Glinatsi, Cecilie H Brahe, Merete L Hetland, Lykke Ørnbjerg, Simon Krabbe, Natalia Manilo

Int J Rheum Dis· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to: 'Mandatory, cost-driven switching from originator etanercept to its biosimilar SB: possible fallout on non-medical switching' by Cantini and Benucci.
Bente Glintborg, Anne Gitte Loft, Emina Omerovic, Oliver Hendricks, Asta Linauskas, Natalia Manilo

Ann Rheum Dis· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry.
Bente Glintborg, Anne Gitte Loft, Emina Omerovic, Oliver Hendricks, Asta Linauskas, Natalia Manilo

Ann Rheum Dis· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in routine care - 2-year outcomes and predictors.
Cecilie Heegaard Brahe, Simon Krabbe, Mikkel Østergaard, Lykke Ørnbjerg, Daniel Glinatsi, Natalia Manilo

Rheumatology (Oxford)· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity and completeness of rheumatoid arthritis diagnoses in the nationwide DANBIO clinical register and the Danish National Patient Registry.
Else Helene Ibfelt, Jan Sørensen, Dorte V Jensen, Lene Dreyer, Berit Schiøttz-Christensen, Natalia Manilo

Clin Epidemiol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry.
Bente Glintborg, Inge Juul Sørensen, Anne Gitte Loft, Hanne Lindegaard, Asta Linauskas, Natalia Manilo

Ann Rheum Dis· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial.
L M Ørnbjerg, M Østergaard, T Jensen, K Hørslev-Petersen, K Stengaard-Pedersen, Natalia Manilo

Clin Rheumatol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis: results from the nationwide registries DANBIO and ICEBIO.
Bente Glintborg, Bjorn Gudbjornsson, Niels Steen Krogh, Emina Omerovic, Natalia Manilo

Rheumatology (Oxford)· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry.
Bente Glintborg, Mikkel Østergaard, Niels Steen Krogh, Ulrik Tarp, Natalia Manilo

Ann Rheum Dis· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis